(firstQuint)PARTNER 3 Trial - Mitral Valve in Valve.

 A prospective, single-arm, multicenter clinical trial.

 This study will enroll patients with symptomatic heart disease due to a failing bioprosthetic mitral valve (stenosed, insufficient, or combined).

.

 PARTNER 3 Trial - Mitral Valve in Valve@highlight

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing mitral bioprosthetic valve.

